Alzheimer’s ‘Miracle’ Drug and the 9-Year LIE
Dear Turapür Today Reader, In early June, the U.S. Food and Drug Administration (FDA) approved the use of the experimental drug aducanumab for early phases of Alzheimer’s disease. This marked the first time the FDA has approved a new therapy for the disease since 2003. Aducanumab was developed for patients with mild cognitive impairment and is intended to...
Alzheimer’s “Miracle” Drug: The Dirty TRUTH
Dear Turapür Today Reader, In case you missed it, late last week the U.S. Food and Drug Administration (FDA) approved the use of the experimental drug aducanumab for early phases of Alzheimer’s disease – the first time the FDA has approved a new therapy since 2003. Aducanumab was developed for patients with mild cognitive impairment and is intended to slow progression of Alzheimer’s disease (not just ease symptoms). ...